相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The evolving landscape of glioblastoma stem cells
Kenneth Yan et al.
CURRENT OPINION IN NEUROLOGY (2013)
Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells
C. Quintavalle et al.
ONCOGENE (2013)
Salinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2
K. H. Koo et al.
CELL DEATH & DISEASE (2013)
Salinomycin - A New Cancer Drug Candidate
Adam Huczynski
CHEMICAL BIOLOGY & DRUG DESIGN (2012)
Inostamycin enhanced TRAIL-induced apoptosis through DR5 upregulation on the cell surface
Kohta Yamamoto et al.
JOURNAL OF ANTIBIOTICS (2012)
Regulating the TRAIL of Destruction: How A20 Protects Glioblastomas from TRAIL-Mediated Death
Inge Verbrugge et al.
CANCER DISCOVERY (2012)
Heterogeneity of primary glioblastoma cells in the expression of caspase-8 and the response to TRAIL-induced apoptosis
Ling Qi et al.
APOPTOSIS (2011)
Salinomycin-induced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarization
Kwang-Youn Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein
Ju-Hwa Kim et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Cisplatin Restores TRAIL Apoptotic Pathway in Glioblastoma-Derived Stem Cells through Up-regulation of DR5 and Down-regulation of c-FLIP
Lijuan Ding et al.
CANCER INVESTIGATION (2011)
Salinomycin inhibits osteosarcoma by targeting its tumor stem cells
Qing-Lian Tang et al.
CANCER LETTERS (2011)
Detecting and targeting mesenchymal-like subpopulations within squamous cell carcinomas
Devraj Basu et al.
CELL CYCLE (2011)
Modulation of CCAAT/Enhancer Binding Protein Homologous Protein (CHOP)-dependent DR5 Expression by Nelfinavir Sensitizes Glioblastoma Multiforme Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
Xiaobing Tian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Lanatoside C sensitizes glioblastoma cells to tumor necrosis factor-related apoptosis-inducing ligand and induces an alternative cell death pathway
Christian E. Badr et al.
NEURO-ONCOLOGY (2011)
Effects of Salinomycin on Cancer Stem Cell in Human Lung Adenocarcinoma A549 Cells
Yi Wang
MEDICINAL CHEMISTRY (2011)
Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells
Desheng Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Salinomycin induces calpain and cytochrome c-mediated neuronal cell death
W. Boehmerle et al.
CELL DEATH & DISEASE (2011)
Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells
Dominik Fuchs et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor
Roberta Riccioni et al.
BLOOD CELLS MOLECULES AND DISEASES (2010)
Kitlow Stem Cells Cause Resistance to Kit/Platelet-Derived Growth Factor α Inhibitors in Murine Gastrointestinal Stromal Tumors
Michael R. Bardsley et al.
GASTROENTEROLOGY (2010)
DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas
Anita C. Bellail et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
Lucia Ricci-Vitiani et al.
NATURE (2010)
Review: On TRAIL for malignant glioma therapy?
J. M. A. Kuijlen et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2010)
Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells
Dominik Fuchs et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
A Novel PTEN-Dependent Link to Ubiquitination Controls FLIPs Stability and TRAIL Sensitivity in Glioblastoma Multiforme
Amith Panner et al.
CANCER RESEARCH (2009)
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Piyush B. Gupta et al.
CELL (2009)
SC68896, a Novel Small Molecule Proteasome Inhibitor, Exerts Antiglioma Activity In vitro and In vivo
Patrick Roth et al.
CLINICAL CANCER RESEARCH (2009)
In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs
D. M. Ashley et al.
BRITISH JOURNAL OF CANCER (2008)
TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiforme
Jos M. A. Kuijlen et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Changing paradigms - An update on the multidisciplinary management of malignant glioma
Roger Stupp et al.
ONCOLOGIST (2006)
Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL-R1 and TRAIL-R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin- and bortezomib-induced cell death
GV Georgakis et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo
L Pukac et al.
BRITISH JOURNAL OF CANCER (2005)
分享论文
